Tiny (“Tiny” or the “Company”) (TSXV: TINY) a Canadian holding company and Dr. Andrew Huberman announce that their majority owned Canadian Yerba Mate Beverage – Mateina –is now available in the United States via drinkMateina.com. The U.S. launch includes a new sugar-free option that was co-developed with Dr. Huberman.

Tiny’s interest in Mateina is held through its private partnership, Tiny Fund I, LP. Dr. Huberman is a neuroscientist and professor in the department of neurobiology at Stanford School of Medicine, and also one of the top podcasters in the world with the Huberman Lab Podcast.

Mateina

Founded in 2017 by Nicolas Beaupré and Elodie Simard, Mateina was born out of a lack of low-sugar and organic Yerba Mate options in the market and is available across Canada at leading retailers like Whole Foods. Cultivated in partnership with a fourth-generation farming family in Misiones, Argentina, the brand offers an array of organic, sustainably farmed yerba mate products. These include non-carbonated, lightly sweetened cold beverages in a variety of flavors (original lemon, peach passion, and grapefruit guava), loose leaf teas, and a new sugar-free option. Nicolas Beaupré and Elodie Simard, continue to operate the business while leveraging the partnership with Tiny and Dr. Huberman.

Management Commentary

“We envision a world where yerba mate is a highly accessible and health-forward beverage that is consumed by hundreds of millions of people in the US and around the world, in the same way coffee and tea are today," said Elodie Simard, co-founder of Mateina. "Partnering with Tiny and Dr. Huberman enables us to introduce Mateina U.S. and globally while also underscoring our commitment to sustainable, organic farming practices in Argentina."

"Yerba mate has been my preferred source of caffeine for more than three decades," said Dr. Huberman. "I often discuss yerba mate's health benefits — emphasizing its high antioxidant content, its role in managing blood sugar, and its possible neuroprotective effects. Collaborating with Mateina to develop a non-smoked, sugar-free version of cold pressed yerba mate was a thrill and I’m so excited to be able to share this drink with the world. I see it as a truly peerless beverage in terms of its positive effects on mind and body."

Andrew Wilkinson, co-founder of Tiny, added, “Tiny has been a huge supporter of Andrew Huberman and we are incredibly excited to partner together on developing and bringing to market this incredible yerba mate brand to the US. We're confident that Mateína will make a significant impact in the U.S. health beverage market, bolstered by Dr. Huberman's expertise and the scientific merits of yerba mate."

About Mateina

Mateina is devoted to delivering high-quality, organic yerba mate beverages. Upholding a strong commitment to sustainability, the company sources its yerba mate directly from family-owned farms in Argentina. The product range, which includes sugar-free and low-sugar options, combines the health benefits of yerba mate with the deep cultural heritage of South America, introducing a novel approach to the energy drink landscape. For more information, visit drinkMateina.com.

About Dr. Andrew Huberman & Huberman Lab

Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. He has made numerous significant contributions to the fields of brain development, brain function and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills and cognitive functioning.

Huberman is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award in 2017, given to the scientist making the most significant discoveries in the study of vision. His lab’s most recent work focuses on the influence of vision and respiration on brain states such as fear and high attention focus and developing rapid and effective tools for mitigating stress and improving sleep and other physiological metrics.

Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals including Nature, Science and Cell and has been featured in TIME, BBC, Scientific American, Discover and other top media outlets.

In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

Alongside hosting the Huberman Lab podcast, Andrew Huberman is the co-founder of Scicomm Media.

For more information about Huberman Lab, please visit www.hubermanlab.com. For more information about Scicomm Media, please visit www.scicommedia.com.

About Tiny

Tiny is a Canadian-based investment company focused primarily on investing and acquiring majority stakes in businesses that it expects to hold over the long-term. The Company is structured to give maximum flexibility to operating management teams by maintaining a focus at the parent company level on only three areas: capital allocation, management, and incentives. This structure enables each company to run independently and focus on what they do best, within an incentive structure that is designed to drive results for both the operating business and ultimately for Tiny and its shareholders.​

Tiny currently has three principle reporting segments: Digital Services, which provides design, engineering, brand positioning and marketing services to help companies of all sizes deliver premium web and mobile products​; E-Commerce Platform, which is home to a complementary portfolio of recurring revenue software businesses that support merchants, as well as digital themes businesses that sell templates to Shopify merchants​; and Creative Platform, which is comprised primarily of Dribbble, the leading social network for designers and digital creatives, as well as a premier online marketplace for digital assets such as fonts and templates.​

For more information, please visit www.tiny.com or refer to the public disclosure documents available under Tiny’s SEDAR+ profile at www.sedarplus.ca.

Cautionary Note Regarding Forward-Looking Information:

This press release contains statements which constitute “forward-looking statements” and “forward-looking information” within the meaning of applicable securities laws (collectively, “forward-looking statements”), including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking statements are often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and forward-looking statements in this press release includes, but is not limited to, information and statements regarding the completion of the transaction and the timing thereof and Company's beliefs regarding the future prospects of Mateina.

Investors are cautioned that forward-looking statements are not based on historical facts but instead reflect the Company’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed thereon, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are the following: changes in general economic, business and political conditions, including challenging global financial conditions and the impact of the novel coronavirus pandemic; competition risks; potential conflicts of interest; changes in applicable laws and regulations both locally and in foreign jurisdictions; compliance with extensive government regulation; and the risks and uncertainties associated with foreign markets.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. The Company does not intend, and does not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240125911476/en/